{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:52:24Z","timestamp":1790722344005,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,4,17]],"date-time":"2014-04-17T00:00:00Z","timestamp":1397692800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"DOI":"10.1038\/cddis.2014.101","type":"journal-article","created":{"date-parts":[[2014,4,17]],"date-time":"2014-04-17T15:01:13Z","timestamp":1397746873000},"page":"e1187-e1187","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":164,"title":["Opposing TNF-\u03b1\/IL-1\u03b2- and BMP-2-activated MAPK signaling pathways converge on Runx2 to regulate BMP-2-induced osteoblastic differentiation"],"prefix":"10.1038","volume":"5","author":[{"given":"R-L","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G-M","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,17]]},"reference":[{"key":"BFcddis2014101_CR1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.cytogfr.2009.10.018","volume":"20","author":"V Rosen","year":"2009","unstructured":"Rosen V . BMP2 signaling in bone development and repair. Cytokine Growth Factor Rev 2009; 20: 475\u2013480.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFcddis2014101_CR2","first-page":"ONS423","volume":"62","author":"D Benglis","year":"2008","unstructured":"Benglis D, Wang MY, Levi AD . A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery. Neurosurgery 2008; 62: ONS423\u2013ONS431 discussion ONS431.","journal-title":"Neurosurgery"},{"key":"BFcddis2014101_CR3","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00264-007-0418-6","volume":"31","author":"WF McKay","year":"2007","unstructured":"McKay WF, Peckham SM, Badura JM . A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft). Int Orthop 2007; 31: 729\u2013734.","journal-title":"Int Orthop"},{"key":"BFcddis2014101_CR4","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.spinee.2011.04.023","volume":"11","author":"EJ Carragee","year":"2011","unstructured":"Carragee EJ, Hurwitz EL, Weiner BK . A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 2011; 11: 471\u2013491.","journal-title":"Spine J"},{"key":"BFcddis2014101_CR5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.spinee.2007.03.005","volume":"7","author":"LM Tumialan","year":"2007","unstructured":"Tumialan LM, Rodts GE . Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion. Spine J 2007; 7: 509\u2013510.","journal-title":"Spine J"},{"key":"BFcddis2014101_CR6","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1097\/01.brs.0000245863.52371.c2","volume":"31","author":"JD Smucker","year":"2006","unstructured":"Smucker JD, Rhee JM, Singh K, Yoon ST, Heller JG . Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine (Phila Pa 1976) 2006; 31: 2813\u20132819.","journal-title":"Spine (Phila Pa 1976)"},{"key":"BFcddis2014101_CR7","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.spinee.2012.11.052","volume":"13","author":"F Taher","year":"2013","unstructured":"Taher F, Lebl DR, Hughes AP, Girardi FP . Contralateral psoas seroma after transpsoas lumbar interbody fusion with bone morphogenetic protein-2 implantation. Spine J 2013; 13: e1\u2013e5.","journal-title":"Spine J"},{"key":"BFcddis2014101_CR8","doi-asserted-by":"publisher","first-page":"E1350","DOI":"10.1097\/BRS.0b013e3181e85756","volume":"35","author":"BN Robin","year":"2010","unstructured":"Robin BN, Chaput CD, Zeitouni S, Rahm MD, Zerris VA, Sampson HW . Cytokine-mediated inflammatory reaction following posterior cervical decompression and fusion associated with recombinant human bone morphogenetic protein-2: a case study. Spine (Phila Pa 1976) 2010; 35: E1350\u2013E1354.","journal-title":"Spine (Phila Pa 1976)"},{"key":"BFcddis2014101_CR9","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/01.bsd.0000211231.83716.4b","volume":"19","author":"JW McClellan","year":"2006","unstructured":"McClellan JW, Mulconrey DS, Forbes RJ, Fullmer N . Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2). J Spinal Disord Tech 2006; 19: 483\u2013486.","journal-title":"J Spinal Disord Tech"},{"key":"BFcddis2014101_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4103\/2152-7806.83726","volume":"2","author":"R Xu","year":"2011","unstructured":"Xu R, Bydon M, Sciubba DM, Witham TF, Wolinsky JP, Gokaslan ZL et al. Safety and efficacy of rhBMP2 in posterior cervical spinal fusion for subaxial degenerative spine disease: analysis of outcomes in 204 patients. Surg Neurol Int 2011; 2: 109.","journal-title":"Surg Neurol Int"},{"key":"BFcddis2014101_CR11","doi-asserted-by":"publisher","first-page":"890","DOI":"10.7326\/0003-4819-158-12-201306180-00006","volume":"158","author":"R Fu","year":"2013","unstructured":"Fu R, Selph S, McDonagh M, Peterson K, Tiwari A, Chou R et al. Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis. Ann Intern Med 2013; 158: 890\u2013902.","journal-title":"Ann Intern Med"},{"key":"BFcddis2014101_CR12","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1097\/SCS.0b013e318256657c","volume":"24","author":"OE Beidas","year":"2013","unstructured":"Beidas OE, Deschamps-Braly JC, Morgan AM, Workman MC, Knotts CD, Denny AD et al. Safety and efficacy of recombinant human bone morphogenetic protein 2 on cranial defect closure in the pediatric population. J Craniofac Surg 2013; 24: 917\u2013922.","journal-title":"J Craniofac Surg"},{"key":"BFcddis2014101_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jama.2009.956","volume":"302","author":"KS Cahill","year":"2009","unstructured":"Cahill KS, Chi JH, Day A, Claus EB . Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA 2009; 302: 58\u201366.","journal-title":"JAMA"},{"key":"BFcddis2014101_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1749-799X-8-1","volume":"8","author":"MF Hoffmann","year":"2013","unstructured":"Hoffmann MF, Jones CB, Sietsema DL . Recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) in posterolateral lumbar spine fusion: complications in the elderly. J Orthop Surg Res 2013; 8: 1.","journal-title":"J Orthop Surg Res"},{"key":"BFcddis2014101_CR15","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/BOT.0b013e3181ed1361","volume":"24","author":"HC Pape","year":"2010","unstructured":"Pape HC, Marcucio R, Humphrey C, Colnot C, Knobe M, Harvey EJ . Trauma-induced inflammation and fracture healing. J Orthop Trauma 2010; 24: 522\u2013525.","journal-title":"J Orthop Trauma"},{"key":"BFcddis2014101_CR16","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/j.1365-2362.2011.02545.x","volume":"41","author":"G Schett","year":"2011","unstructured":"Schett G . Effects of inflammatory and anti-inflammatory cytokines on the bone. Eur J Clin Invest 2011; 41: 1361\u20131366.","journal-title":"Eur J Clin Invest"},{"key":"BFcddis2014101_CR17","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jhsa.2011.10.007","volume":"37","author":"AW Ritting","year":"2012","unstructured":"Ritting AW, Weber EW, Lee MC . Exaggerated inflammatory response and bony resorption from BMP-2 use in a pediatric forearm nonunion. J Hand Surg [Am] 2012; 37: 316\u2013321.","journal-title":"J Hand Surg [Am]"},{"key":"BFcddis2014101_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/BPO.0b013e3181cec35b","volume":"30","author":"KM MacDonald","year":"2010","unstructured":"MacDonald KM, Swanstrom MM, McCarthy JJ, Nemeth BA, Guliani TA, Noonan KJ . Exaggerated inflammatory response after use of recombinant bone morphogenetic protein in recurrent unicameral bone cysts. J Pediatr Orthop 2010; 30: 199\u2013205.","journal-title":"J Pediatr Orthop"},{"key":"BFcddis2014101_CR19","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.spinee.2011.02.001","volume":"11","author":"KB Lee","year":"2011","unstructured":"Lee KB, Murray SS, Taghavi CE, Song KJ, Brochmann EJ, Johnson JS et al. Bone morphogenetic protein-binding peptide reduces the inflammatory response to recombinant human bone morphogenetic protein-2 and recombinant human bone morphogenetic protein-7 in a rodent model of soft-tissue inflammation. Spine J 2011; 11: 568\u2013576.","journal-title":"Spine J"},{"key":"BFcddis2014101_CR20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.biomaterials.2011.09.050","volume":"33","author":"J Ratanavaraporn","year":"2012","unstructured":"Ratanavaraporn J, Furuya H, Tabata Y . Local suppression of pro-inflammatory cytokines and the effects in BMP-2-induced bone regeneration. Biomaterials 2012; 33: 304\u2013316.","journal-title":"Biomaterials"},{"key":"BFcddis2014101_CR21","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/BRS.0b013e31827eca09","volume":"38","author":"Y Tan","year":"2013","unstructured":"Tan Y, Montgomery SR, Aghdasi BG, Inoue H, Kaner T, Tian H et al. The effect of corticosteroid administration on soft-tissue inflammation associated with rhBMP-2 use in a rodent model of inflammation. Spine (Phila Pa 1976) 2013; 38: 806\u2013813.","journal-title":"Spine (Phila Pa 1976)"},{"key":"BFcddis2014101_CR22","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1097\/BRS.0b013e31829cf348","volume":"38","author":"C Xiong","year":"2013","unstructured":"Xiong C, Daubs MD, Montgomery SR, Aghdasi B, Inoue H, Tian H et al. BMP-2 adverse reactions treated with human dose equivalent dexamethasone in a rodent model of soft-tissue inflammation. Spine (Phila Pa 1976) 2013; 38: 1640\u20131647.","journal-title":"Spine (Phila Pa 1976)"},{"key":"BFcddis2014101_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1089\/scd.2013.0345","volume":"23","author":"RL Huang","year":"2014","unstructured":"Huang RL, Yuan Y, Zou GM, Liu G, Tu J, Li Q . LPS-stimulated inflammatory environment inhibits BMP-2-induced osteoblastic differentiation through crosstalk between TLR4\/MyD88\/NF-kappaB and BMP\/Smad signaling. Stem Cells Dev 2014; 23: 277\u2013289.","journal-title":"Stem Cells Dev"},{"issue":"Suppl 1","key":"BFcddis2014101_CR24","first-page":"S7","volume":"22","author":"DP ten","year":"2006","unstructured":"ten DP . Bone morphogenetic protein signal transduction in bone. Curr Med Res Opin 2006; 22 (Suppl 1): S7\u201311.","journal-title":"Curr Med Res Opin"},{"key":"BFcddis2014101_CR25","doi-asserted-by":"publisher","first-page":"272","DOI":"10.7150\/ijbs.2929","volume":"8","author":"G Chen","year":"2012","unstructured":"Chen G, Deng C, Li YP . TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 2012; 8: 272\u2013288.","journal-title":"Int J Biol Sci"},{"key":"BFcddis2014101_CR26","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/jbmr.1548","volume":"27","author":"YF Huang","year":"2012","unstructured":"Huang YF, Lin JJ, Lin CH, Su Y, Hung SC . c-Jun N-terminal kinase 1 negatively regulates osteoblastic differentiation induced by BMP2 via phosphorylation of Runx2 at Ser104. J Bone Miner Res 2012; 27: 1093\u20131105.","journal-title":"J Bone Miner Res"},{"key":"BFcddis2014101_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/cr.2008.302","volume":"19","author":"X Guo","year":"2009","unstructured":"Guo X, Wang XF . Signaling cross-talk between TGF-beta\/BMP and other pathways. Cell Res 2009; 19: 71\u201388.","journal-title":"Cell Res"},{"key":"BFcddis2014101_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/35065000","volume":"410","author":"L Chang","year":"2001","unstructured":"Chang L, Karin M . Mammalian MAP kinase signalling cascades. Nature 2001; 410: 37\u201340.","journal-title":"Nature"},{"key":"BFcddis2014101_CR29","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1126\/science.1072682","volume":"298","author":"GL Johnson","year":"2002","unstructured":"Johnson GL, Lapadat R . Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002; 298: 1911\u20131912.","journal-title":"Science"},{"key":"BFcddis2014101_CR30","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1152\/physrev.00028.2011","volume":"92","author":"JM Kyriakis","year":"2012","unstructured":"Kyriakis JM, Avruch J . Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev 2012; 92: 689\u2013737.","journal-title":"Physiol Rev"},{"key":"BFcddis2014101_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/MMBR.00031-10","volume":"75","author":"M Cargnello","year":"2011","unstructured":"Cargnello M, Roux PP . Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 2011; 75: 50\u201383.","journal-title":"Microbiol Mol Biol Rev"},{"key":"BFcddis2014101_CR32","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.febslet.2007.12.006","volume":"582","author":"N Bokui","year":"2008","unstructured":"Bokui N, Otani T, Igarashi K, Kaku J, Oda M, Nagaoka T et al. Involvement of MAPK signaling molecules and Runx2 in the NELL1-induced osteoblastic differentiation. FEBS Lett 2008; 582: 365\u2013371.","journal-title":"FEBS Lett"},{"key":"BFcddis2014101_CR33","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/jbmr.296","volume":"26","author":"H Liu","year":"2011","unstructured":"Liu H, Liu Y, Viggeswarapu M, Zheng Z, Titus L, Boden SD . Activation of c-Jun NH(2)-terminal kinase 1 increases cellular responsiveness to BMP-2 and decreases binding of inhibitory Smad6 to the type 1 BMP receptor. J Bone Miner Res 2011; 26: 1122\u20131132.","journal-title":"J Bone Miner Res"},{"key":"BFcddis2014101_CR34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/jbmr.1798","volume":"28","author":"N Yang","year":"2013","unstructured":"Yang N, Wang G, Hu C, Shi Y, Liao L, Shi S et al. Tumor necrosis factor alpha suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis. J Bone Miner Res 2013; 28: 559\u2013573.","journal-title":"J Bone Miner Res"},{"key":"BFcddis2014101_CR35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1084\/jem.20111566","volume":"209","author":"B Zhao","year":"2012","unstructured":"Zhao B, Grimes SN, Li S, Hu X, Ivashkiv LB . TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J. J Exp Med 2012; 209: 319\u2013334.","journal-title":"J Exp Med"},{"key":"BFcddis2014101_CR36","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.joca.2008.11.011","volume":"17","author":"DC Lacey","year":"2009","unstructured":"Lacey DC, Simmons PJ, Graves SE, Hamilton JA . Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation. Osteoarthritis Cartilage 2009; 17: 735\u2013742.","journal-title":"Osteoarthritis Cartilage"},{"key":"BFcddis2014101_CR37","doi-asserted-by":"publisher","first-page":"E149","DOI":"10.1097\/BRS.0b013e3181f2d1ec","volume":"36","author":"KB Lee","year":"2011","unstructured":"Lee KB, Taghavi CE, Song KJ, Sintuu C, Yoo JH, Keorochana G et al. Inflammatory characteristics of rhBMP-2 in vitro and in an in vivo rodent model. Spine (Phila Pa 1976) 2011; 36: E149\u2013E154.","journal-title":"Spine (Phila Pa 1976)"},{"key":"BFcddis2014101_CR38","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1002\/jor.22160","volume":"30","author":"KB Lee","year":"2012","unstructured":"Lee KB, Taghavi CE, Murray SS, Song KJ, Keorochana G, Wang JC . BMP induced inflammation: a comparison of rhBMP-7 and rhBMP-2. J Orthop Res 2012; 30: 1985\u20131994.","journal-title":"J Orthop Res"},{"key":"BFcddis2014101_CR39","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.2106\/JBJS.K.00469","volume":"94","author":"HW Bae","year":"2012","unstructured":"Bae HW, Strenge KB, Ashraf N, Badura JM, Peckham SM, McKay WF . Transient soft-tissue edema associated with implantation of increasing doses of rhBMP-2 on an absorbable collagen sponge in an ectopic rat model. J Bone Joint Surg Am 2012; 94: 1845\u20131852.","journal-title":"J Bone Joint Surg Am"},{"key":"BFcddis2014101_CR40","doi-asserted-by":"publisher","first-page":"E691","DOI":"10.1097\/BRS.0b013e31828cb977","volume":"38","author":"W Hsu","year":"2013","unstructured":"Hsu W, Polavarapu M, Riaz R, Larson A, Jared JD, Ghodasra J et al. Characterizing the host response to rhBMP-2 in a rat spinal arthrodesis model. Spine (Phila Pa 1976) 2013; 38: E691\u2013E698.","journal-title":"Spine (Phila Pa 1976)"},{"key":"BFcddis2014101_CR41","doi-asserted-by":"publisher","first-page":"e41627","DOI":"10.1371\/journal.pone.0041627","volume":"7","author":"A Ao","year":"2012","unstructured":"Ao A, Hao J, Hopkins CR, Hong CC . DMH1 a novel BMP small molecule inhibitor, increases cardiomyocyte progenitors and promotes cardiac differentiation in mouse embryonic stem cells. PLoS One 2012; 7: e41627.","journal-title":"PLoS One"},{"key":"BFcddis2014101_CR42","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1021\/cn300029t","volume":"3","author":"MD Neely","year":"2012","unstructured":"Neely MD, Litt MJ, Tidball AM, Li GG, Aboud AA, Hopkins CR et al. DMH1, a highly selective small molecule BMP inhibitor promotes neurogenesis of hiPSCs: comparison of PAX6 and SOX1 expression during neural induction. ACS Chem Neurosci 2012; 3: 482\u2013491.","journal-title":"ACS Chem Neurosci"},{"key":"BFcddis2014101_CR43","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/jor.21099","volume":"28","author":"FH Lin","year":"2010","unstructured":"Lin FH, Chang JB, McGuire MH, Yee JA, Brigman BE . Biphasic effects of interleukin-1beta on osteoblast differentiation in vitro. J Orthop Res 2010; 28: 958\u2013964.","journal-title":"J Orthop Res"},{"key":"BFcddis2014101_CR44","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1210\/endo.141.11.7739","volume":"141","author":"L Gilbert","year":"2000","unstructured":"Gilbert L, He X, Farmer P, Boden S, Kozlowski M, Rubin J et al. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 2000; 141: 3956\u20133964.","journal-title":"Endocrinology"},{"key":"BFcddis2014101_CR45","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bone.2009.04.252","volume":"45","author":"K Hess","year":"2009","unstructured":"Hess K, Ushmorov A, Fiedler J, Brenner RE, Wirth T . TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway. Bone 2009; 45: 367\u2013376.","journal-title":"Bone"},{"key":"BFcddis2014101_CR46","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1073\/pnas.1018501108","volume":"108","author":"GE Glass","year":"2011","unstructured":"Glass GE, Chan JK, Freidin A, Feldmann M, Horwood NJ, Nanchahal J . TNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells. Proc Natl Acad Sci USA 2011; 108: 1585\u20131590.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2014101_CR47","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1677\/JOE-07-0532","volume":"196","author":"M Yamashita","year":"2008","unstructured":"Yamashita M, Otsuka F, Mukai T, Otani H, Inagaki K, Miyoshi T et al. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras\/Rho-mitogen-activated protein kinase pathway. J Endocrinol 2008; 196: 601\u2013613.","journal-title":"J Endocrinol"},{"key":"BFcddis2014101_CR48","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.mce.2010.05.004","volume":"325","author":"Y Matsumoto","year":"2010","unstructured":"Matsumoto Y, Otsuka F, Takano M, Mukai T, Yamanaka R, Takeda M et al. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells. Mol Cell Endocrinol 2010; 325: 118\u2013127.","journal-title":"Mol Cell Endocrinol"},{"key":"BFcddis2014101_CR49","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1089\/scd.2012.0226","volume":"22","author":"Y Tang","year":"2013","unstructured":"Tang Y, Xie H, Chen J, Geng L, Chen H, Li X et al. Activated NF-\u03baB in bone marrow mesenchymal stem cells from systemic lupus erythematosus patients inhibits osteogenic differentiation through downregulating Smad signaling. Stem Cells Dev 2013; 22: 668\u2013678.","journal-title":"Stem Cells Dev"},{"key":"BFcddis2014101_CR50","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.bbrc.2007.03.099","volume":"356","author":"T Mukai","year":"2007","unstructured":"Mukai T, Otsuka F, Otani H, Yamashita M, Takasugi K, Inagaki K et al. TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK\/JNK signaling. Biochem Biophys Res Commun 2007; 356: 1004\u20131010.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcddis2014101_CR51","doi-asserted-by":"publisher","first-page":"35987","DOI":"10.1074\/jbc.M109.070540","volume":"284","author":"M Yamazaki","year":"2009","unstructured":"Yamazaki M, Fukushima H, Shin M, Katagiri T, Doi T, Takahashi T et al. Tumor necrosis factor alpha represses bone morphogenetic protein (BMP) signaling by interfering with the DNA binding of Smads through the activation of NF-kappaB. J Biol Chem 2009; 284: 35987\u201335995.","journal-title":"J Biol Chem"},{"key":"BFcddis2014101_CR52","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00296-010-1688-7","volume":"31","author":"H Eda","year":"2011","unstructured":"Eda H, Shimada H, Beidler DR, Monahan JB . Proinflammatory cytokines, IL-1beta and TNF-alpha, induce expression of interleukin-34 mRNA via JNK- and p44\/42 MAPK-NF-kappaB pathway but not p38 pathway in osteoblasts. Rheumatol Int 2011; 31: 1525\u20131530.","journal-title":"Rheumatol Int"},{"key":"BFcddis2014101_CR53","doi-asserted-by":"publisher","first-page":"29494","DOI":"10.1074\/jbc.M113.471268","volume":"288","author":"E Ferreira","year":"2013","unstructured":"Ferreira E, Porter RM, Wehling N, O'Sullivan RP, Liu F, Boskey A et al. Inflammatory cytokines induce a unique mineralizing phenotype in mesenchymal stem cells derived from human bone marrow. J Biol Chem 2013; 288: 29494\u201329505.","journal-title":"J Biol Chem"},{"key":"BFcddis2014101_CR54","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1146\/annurev-cellbio-101512-122347","volume":"29","author":"MB Greenblatt","year":"2013","unstructured":"Greenblatt MB, Shim JH, Glimcher LH . Mitogen-activated protein kinase pathways in osteoblasts. Annu Rev Cell Dev Biol 2013; 29: 63\u201379.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"BFcddis2014101_CR55","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1359\/jbmr.090305","volume":"24","author":"C Vincent","year":"2009","unstructured":"Vincent C, Findlay DM, Welldon KJ, Wijenayaka AR, Zheng TS, Haynes DR et al. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. J Bone Miner Res 2009; 24: 1434\u20131449.","journal-title":"J Bone Miner Res"},{"key":"BFcddis2014101_CR56","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1359\/jbmr.2003.18.11.2060","volume":"18","author":"J Guicheux","year":"2003","unstructured":"Guicheux J, Lemonnier J, Ghayor C, Suzuki A, Palmer G, Caverzasio J . Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J Bone Miner Res 2003; 18: 2060\u20132068.","journal-title":"J Bone Miner Res"},{"key":"BFcddis2014101_CR57","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1359\/jbmr.2002.17.10.1785","volume":"17","author":"C Higuchi","year":"2002","unstructured":"Higuchi C, Myoui A, Hashimoto N, Kuriyama K, Yoshioka K, Yoshikawa H et al. Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix. J Bone Miner Res 2002; 17: 1785\u20131794.","journal-title":"J Bone Miner Res"},{"key":"BFcddis2014101_CR58","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0014-5793(01)03236-7","volume":"510","author":"F Vinals","year":"2002","unstructured":"Vinals F, Lopez-Rovira T, Rosa JL, Ventura F . Inhibition of PI3K\/p70 S6K and p38 MAPK cascades increases osteoblastic differentiation induced by BMP-2. FEBS Lett 2002; 510: 99\u2013104.","journal-title":"FEBS Lett"},{"key":"BFcddis2014101_CR59","doi-asserted-by":"publisher","first-page":"36410","DOI":"10.1074\/jbc.M110.142307","volume":"285","author":"JH Jun","year":"2010","unstructured":"Jun JH, Yoon WJ, Seo SB, Woo KM, Kim GS, Ryoo HM et al. BMP2-activated Erk\/MAP kinase stabilizes Runx2 by increasing p300 levels and histone acetyltransferase activity. J Biol Chem 2010; 285: 36410\u201336419.","journal-title":"J Biol Chem"}],"container-title":["Cell Death & Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cddis2014101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cddis2014101","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2014101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:27:27Z","timestamp":1672961247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2014101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,17]]},"references-count":59,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4]]}},"alternative-id":["BFcddis2014101"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2014.101","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,17]]},"assertion":[{"value":"29 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}